HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome
Nerea Hermida, Andreas Markl, Julien Hamelet, Tim Van Assche, Annelies Vanderper, Paul Herijgers, Marc van Bilsen, Denise Hilfiker-Kleiner, Gauthier Noppe, Christophe Beauloye, Sandrine Horman, Jean-Luc Balligand*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome'. Together they form a unique fingerprint.